Filing Details

Accession Number:
0001179110-14-009305
Form Type:
4
Zero Holdings:
No
Publication Time:
2014-05-28 20:02:19
Reporting Period:
2014-05-23
Filing Date:
2014-05-28
Accepted Time:
2014-05-28 20:02:19
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
815094 Abiomed Inc ABMD Surgical & Medical Instruments & Apparatus (3841) 042743260
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1456804 G Michael Howley C/O Abiomed, Inc.
22 Cherry Hill Drive
Danvers MA 01923
Vp, Global Sales & Marketing No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $.01 Par Value Disposition 2014-05-23 3,789 $20.96 70,697 No 4 S Direct
Common Stock, $.01 Par Value Disposition 2014-05-27 5,434 $21.21 65,263 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Stock Option (Right to Buy) $5.23 2009-03-05 2019-03-05 25,000 25,000 Direct
Common Stock Stock Option (right to buy) $5.86 2010-03-31 2019-05-28 15,000 15,000 Direct
Common Stock Stock Option (right to buy) $10.03 2011-06-03 2020-06-03 30,000 30,000 Direct
Common Stock Stock Option (Right to buy) $22.44 2013-05-22 2022-05-22 25,000 25,000 Direct
Common Stock Stock Option (Right to Buy) $23.15 2014-05-14 2023-05-14 25,000 25,000 Direct
Common Stock Stock Option (Right to Buy) $21.55 2015-05-14 2024-05-14 25,000 25,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2019-03-05 25,000 25,000 Direct
2019-05-28 15,000 15,000 Direct
2020-06-03 30,000 30,000 Direct
2022-05-22 25,000 25,000 Direct
2023-05-14 25,000 25,000 Direct
2024-05-14 25,000 25,000 Direct
Footnotes
  1. Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
  2. These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
  3. These options became exerciseable upon the achievement of a certain performance milestone.
  4. Sale of common stock pursuant to reporting owner's 10b5-1 plan sold to pay tax obligations upon vesting.
  5. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $20.8600 and $21.4450. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
  6. These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
  7. This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $21.0000 and $21.5700. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.